April 9, 2020
Tiziana makes investigational new technology to treat COVID-19 infections
Tiziana Life Sciences said Thursday it has developed investigational new technology to treat COVID-19 infections.
Pharmaceuticals, Biotechnology and Life Sciences
Category: North America
April 7, 2020
Alvogen wraps up sale of its Central and Eastern European business to Zentiva Group
Alvogen announced today the completion of the sale of its Central and Eastern European (CEE) business to Zentiva for an undisclosed value. The sale of the company’s CEE platform includes over 200 generic and over-the-counter products across multiple therapeutic areas and covering 14 key markets.
April 6, 2020
Care Access Research in validation trial with FDA for new at-home COVID-19 test
Care Access Research on Friday said it was leading a validation trial with the FDA for a new at-home COVID-19 test developed by a private genomics lab that manufactures DNA screening kits.
April 1, 2020
Medical Professionals Across Merck & Co., Inc., Pfizer Inc., and Eli Lilly and Company Activate to Support Health Systems, First Responders and Patients Amid COVID-19 Pandemic
Three leading biopharmaceutical companies have announced programs enabling employees with medical and laboratory expertise to volunteer their services to local…
March 30, 2020
IMV Inc. Provides Updates on the Development of DPX-COVID-19 Vaccine and Ongoing Business and Clinical Operations
DARTMOUTH, Nova Scotia–(BUSINESS WIRE)–IMV Inc. (Nasdaq: IMV) (TSX: IMV), a clinical-stage biopharmaceutical company (the “Company” or “IMV”), today provided updates…
March 24, 2020
Why you should continue to vaccinate your kids?
You want to do what is excellent for your kids. You know about the importance of baby gates, car seats, and other ways to keep them secure. But, did you know that the most excellent way to protect your kids is to make sure they have all of their vaccinations?
March 24, 2020
FDA OKs Pfizer’s SNDA for expanded indication of EUCRISA ointment, 2%, in children as young as 3 months of age with mild-to-moderate atopic dermatitis
EUCRISA is the first and only 100% steroid-free, topical prescription medication approved for patients as young as 3 months of…
March 24, 2020
Novavax with positive score in Phase 3 of NanoFlu
Novavax published positive top-line results of its pivotal Phase 3 clinical trial of NanoFlu, its recombinant quadrivalent seasonal influenza vaccine candidate with its proprietary Matrix-M adjuvant, in adults aged 65 and older.
March 24, 2020
Roche testing with BARDA Actemra’s potential utility in severe COVID-19 pneumonia patients. Working on availability of COVID 19-tests.
Roche said Tuesday it started testing Actemra (tocilizumab) with the Biomedical Advanced Research and Development Authority (BARDA)on top of standard of care in hospitalised adult patients with severe COVID-19 pneumonia compared to placebo on top of standard of care.
March 23, 2020
US clinical trial site concerns over COVID-19 impact on enrollment jumps by 124% over past week
European site enrollment concerns grow to 85% NORTHBROOK, Ill.–(BUSINESS WIRE)–#COVID19–Over the course of just one week, US clinical research study…